Clinical value of interferon-inducible protein-10 in diagnosis and treatment of diabetes and active tuberculosis

何花,周玉皆,冯枭,宋梅梅,文高艳,朱珠,黄磊,费贤树,袁广琴
DOI: https://doi.org/10.3969/j.issn.1671-6264.2015.06.013
2015-01-01
Abstract:Objective:To investigate the value of interferon-inducible protein-10 (IP-10) in clinical diagnosis and treatment of diabetes and active tuberculosis .Methods:10 patients with diabetes and active tuberculosis ,34 patients with active tuberculosis, 10 patients with non-tuberculosis pulmonary disease, 10 patients with diabetes, and 12 healthy volunteers were enrolled for serum IP-10 detection and statistical analysis .Serum IP-10 levels were re-examined in diabetes patients with active pulmonary tuberculosis who received anti-tuberculosis treatment for two months , and the statistical analysis was performed .Results: The serum IP-10 concentrations were ( 410.35 ±121.36 ) , ( 195.61 ± 70.71),(106.27 ±52.34),(112.77 ±32.47),(48.12 ±31.43)ng· L-1 in diabetes and active tuberculosis group , active tuberculosis group , non-tuberculosis pulmonary disease group , diabetes group and healthy volunteers group , respectively .The serum IP-10 concentrations in patients with diabetes and active tuberculosis were significantly higher than the other 4 groups ( P<0.01) .Diabetes with active pulmonary tuberculosis patients exhibited decreased serum IP-10 levels after anti-tuberculosis treatment for two months (P<0.01).Conclusion:Serum IP-10 concentration increases in patients with diabetes and active tuberculosis , and decreases after anti-tuberculosis treatment .IP-10 could be used as an auxiliary index in the diagnosis and treatment of diabetes and active tuberculosis .
What problem does this paper attempt to address?